| Predicted Trait | |
| Reported Trait | Lung cancer |
| Mapped Trait(s) | lung adenocarcinoma (EFO_0000571) |
| Score Construction | |
| PGS Name | PRS_LC_C |
| Development Method | |
| Name | Genomewide-significant SNPs, filtered to be specific to Chinese ancestry individuals |
| Parameters | Meta-anlaysis p-value ≤5·0 × 10−8; MAF < 0.01 (in Chinese populations); r2 >= 0.1; Chinese-specific association p-value < 0.00125 |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 19 |
| Effect Weight Type | ln(OR) |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000049 |
| Citation (link to publication) | Dai J et al. Lancet Respir Med (2019) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 51.1% East Asian: 48.9% 54,475 individuals (100%) |
| PGS Evaluation | East Asian: 85.7% European: 14.3% 7 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST008834 Europe PMC: 31326317 |
26,655 individuals | East Asian | NR |
GWAS Catalog: GCST008834 Europe PMC: 31326317 |
27,820 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM000190 | PSS000109| East Asian Ancestry| 95,408 individuals |
PGP000049 | Dai J et al. Lancet Respir Med (2019) |
Reported Trait: Incident lung cancer | — | — | HR (High genetic risk: top 5% vs. bottom 5% of PRS): 2.37 [1.64, 3.44] HR (Intermediate genetic risk: 5-95% vs. bottom 5% of PRS): 1.6 [1.17, 2.2] |
age, sex, source of region, smoking status | — |
| PPM015573 | PSS009987| East Asian Ancestry| 19,546 individuals |
PGP000387 | Qin N et al. Lancet Oncol (2022) |Ext. |
Reported Trait: Lung cancer | — | — | Odds ratio (OR, high vs low risk): 2.18 [2.00, 2.38] | — | — |
| PPM015575 | PSS009987| East Asian Ancestry| 19,546 individuals |
PGP000387 | Qin N et al. Lancet Oncol (2022) |Ext. |
Reported Trait: Lung cancer x autosomal mosaic loss abnormalities interaction | OR: 2.36 [1.09, 5.08] | — | — | — | — |
| PPM018700 | PSS011073| East Asian Ancestry| 381 individuals |
PGP000494 | Ho PJ et al. Elife (2023) |Ext. |
Reported Trait: Lung cancer | — | AUROC: 0.68 [0.65, 0.71] | Hazard ratio (HR, high vs low tertile): 2.01 [1.44, 2.81] | age at recruitment | — |
| PPM020283 | PSS011324| European Ancestry| 1,202 individuals |
PGP000539 | Lebrett MB et al. Genet Med (2023) |Ext. |
Reported Trait: Lung cancer | — | AUROC: 0.726 [0.698, 0.754] | — | Age, sex, current smoking status, BMI, forced expiratory volume in 1 second/forced vital capacity ratio | — |
| PPM021774 | PSS011793| East Asian Ancestry| 100,615 individuals |
PGP000678 | Zhu M et al. Int J Epidemiol (2023) |Ext. |
Reported Trait: Incident lung cancer | HR: 1.19 [1.13, 1.25] | — | — | Age, sex, smoking status, BMI, highest education level, family history of cancer, personal medical history (previous cancer diagnoses and chronic obstructive pulmonary disease), the forced expiratory volume in 1 second, 10 PCs | — |
| PPM022188 | PSS011836| East Asian Ancestry| 1,197 individuals |
PGP000687 | Lee PH et al. JCO Precis Oncol (2024) |Ext. |
Reported Trait: Incident non-small cell lung cancer | — | — | Hazard ratio (HR, high vs low PGS quartile): 2.33 [0.6, 9.04] | Age, smoking, family history of lung cancer | — |
| PPM022189 | PSS011835| East Asian Ancestry| 1,090 individuals |
PGP000687 | Lee PH et al. JCO Precis Oncol (2024) |Ext. |
Reported Trait: Incident non-small cell lung cancer | — | — | Hazard ratio (HR, high vs low PGS quartile): 2.97 [1.25, 7.07] | Age, smoking, family history of lung cancer | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009987 | — | — | [ ,
63.0 % Male samples |
— | East Asian (Chinese) |
— | NR | NJLCC |
| PSS011835 | — | Median = 10.7 years | [ ,
0.0 % Male samples |
— | East Asian (Chinese) |
— | TPMI | — |
| PSS011836 | — | Median = 10.0 years | [ ,
100.0 % Male samples |
— | East Asian (Chinese) |
— | TPMI | — |
| PSS000109 | Participants were followed-up for cancer events mainly through linkage with official death certificates, chronic disease registries, and the Chinese national health insurance system. | Median = 10.44 years | [ ,
42.93 % Male samples |
Mean = 53.67 years Se = 10.98 years |
East Asian (Chinese) |
— | CKB | — |
| PSS011073 | — | — | 381 individuals, 100.0 % Male samples |
Median = 60.0 years IQR = [55.0, 64.0] years |
East Asian (Chinese) |
— | SCHS | — |
| PSS011793 | — | — | [
|
— | East Asian (Chinese) |
— | CKB | — |
| PSS011324 | — | — | [ ,
47.0 % Male samples |
Median = 65.0 years | European | — | MCRC | — |